OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14481-14526
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Fragment-to-Lead Medicinal Chemistry Publications in 2022
Andrew J. Woodhead, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2287-2304
Closed Access | Times Cited: 15

E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology
Iacovos N. Michaelides, Gavin W. Collie
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3173-3194
Open Access | Times Cited: 26

Recent progress and applications of small molecule inhibitors of Keap1–Nrf2 axis for neurodegenerative diseases
Jing Wang, Yu Cao, Lu Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115998-115998
Closed Access | Times Cited: 17

Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16

Design of Tracers in Fluorescence Polarization Assay for Extensive Application in Small Molecule Drug Discovery
Liwen Hua, Danni Wang, Keran Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10934-10958
Closed Access | Times Cited: 13

Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access

Electrochemical Nickel-Catalyzed C(sp2)-H Functionalization of Tropones with Aldehydes
Andrea Brunetti, Sofia Kiriakidi, Mauro Garbini, et al.
ACS Catalysis (2025), pp. 3184-3190
Closed Access

Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor
Kazuki Otake, Minoru Ubukata, Noboru Nagahashi, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 658-665
Open Access | Times Cited: 12

Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11

Modulation of NRF2/KEAP1-Mediated Oxidative Stress for Cancer Treatment by Natural Products Using Pharmacophore-Based Screening, Molecular Docking, and Molecular Dynamics Studies
Abdulrahim A. Alzain, Rua M. Mukhtar, Nihal Abdelmoniem, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6003-6003
Open Access | Times Cited: 9

Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 3

Efficient Sequential Detection of Two Antibiotics Using a Fiber-Optic Surface Plasmon Resonance Sensor
Ze Zhao, Huiting Yin, Jingzhe Xiao, et al.
Sensors (2024) Vol. 24, Iss. 7, pp. 2126-2126
Open Access | Times Cited: 3

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
Tim Kirkman, Catharina dos Santos Silva, Manuela Tosin, et al.
ChemMedChem (2024) Vol. 19, Iss. 24
Closed Access | Times Cited: 3

Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
Yuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3

Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors
Kazuki Otake, Yoshinori Hara, Minoru Ubukata, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3741-3763
Closed Access | Times Cited: 2

Drug Discovery Approaches to Target E3 Ligases
A. Rodríguez-Gimeno, Carles Galdeano
ChemBioChem (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2

A cell-active cyclic peptide targeting the Nrf2/Keap1 protein–protein interaction
Jessica Iegre, Soňa Krajčovičová, Anders Gunnarsson, et al.
Chemical Science (2023) Vol. 14, Iss. 39, pp. 10800-10805
Open Access | Times Cited: 6

A Novel Analog of the Natural Product Fraxinellone Protects against Endogenous and Exogenous Neurotoxicants
Anna E. Bartman, Mersad Raeisi, Clarence D. Peiris, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2612-2622
Open Access | Times Cited: 1

Site-Selective Gold-Catalyzed Alkylation of α-Aminotropones with Allenes
Giulio Gallorini, Sofia Kiriakidi, Sara Bellini, et al.
Organic Letters (2024)
Closed Access | Times Cited: 1

NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination
Jin‐A Lee, Pureum Jeon, Hyun-Ji Ham, et al.
Research Square (Research Square) (2024)
Open Access

Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
Qingxin Li, CongBao Kang
Molecules (2024) Vol. 29, Iss. 23, pp. 5748-5748
Open Access

NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination
Pureum Jeon, Hyun-Ji Ham, Haneul Choi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top